查看購物車
  • Simplified Chinese
  • English
亞太地區體外診斷市場預測至 2030 年 - 區域分析 - 按產品和服務、技術、應用和最終用戶
市場調查報告書
商品編碼
1463560

亞太地區體外診斷市場預測至 2030 年 - 區域分析 - 按產品和服務、技術、應用和最終用戶

Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 121 Pages | 訂單完成後即時交付

價格

亞太體外診斷市場預計將從2022年的191.0918億美元成長到2030年的309.4327億CAGR。

IVD 技術與數位健康解決方案的整合推動亞太體外診斷市場

IVD 用於臨床、實驗室和門診環境，其具體目的是幫助檢測疾病，從而幫助選擇適當的治療方案。 IVD 技術與數位健康解決方案的整合正在全球範圍內受到關注。數據分析、人工智慧和遠端監控增強了診斷測試的價值，從而實現更好的患者管理和結果。與數位健康解決方案整合的 IVD 技術可以納入臨床決策支援系統。正如世界衛生組織所認知到的，數位健康解決方案可以幫助檢測疾病。人工智慧健康機器人和其他類似的新興解決方案可能會為患者護理帶來機會，並解決高成本和時間要求等挑戰。在基於基因組測試的診斷中，深度學習可以識別癌細胞，確定其類型，並根據特定樣本的圖像預測腫瘤中可能發生哪些突變。體外診斷中的人工智慧和機器學習 (AI/ML) 正在徹底改變醫療設備的開發。這些現代診斷系統促進基於數位影像分析的診斷，從而改善醫療決策。智慧診斷是一種可擴展性極強的 IVD 解決方案，它使用人工智慧，其性能優於基於實驗室的診斷，而價格僅為實驗室診斷的一小部分。此外，這種類型的診斷可以透過獨特的化學和生物特徵檢測和分析來得出新興特徵。因此，IVD 與數位健康技術的整合可能會在未來幾年為體外診斷市場提供利潤豐厚的機會。

亞太地區體外診斷市場概況

亞太地區體外診斷市場已細分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。中國市場的成長很大程度上歸功於疾病診斷意識的不斷提高。由於全國疾病流行率較高，印度在體外診斷方面佔據第三大佔有率。上述因素對亞太地區體外診斷市場的成長有重要影響。中國的癌症發生率和死亡率不斷上升，這使得癌症成為過去十年中國的首要死因。大多數病例增加是由於人口成長（特別是老年人口激增）和社會人口變化造成的。臨床試驗實驗室服務機構 Q2 Solutions 與廣州金域診斷有限公司合作，為中國市場開發體外診斷產品和伴隨診斷 (CDx)。此外，一些參與者正在投資擴大癌症生物標記市場。 2018 年 8 月，益普索 (Ipsos) 醫療保健服務線推出了聯合實驗室繪圖研究和腫瘤分子診斷 (MDx) 監測器。這兩項研究將在中國一二線城市提供全面的腫瘤生物標記測試。

亞太地區體外診斷市場收入及 2030 年預測（百萬美元）

亞太地區體外診斷市場細分

亞太地區體外診斷市場分為產品和服務、技術、應用、最終用戶和國家。

根據產品和服務，亞太體外診斷市場分為試劑和試劑盒、儀器以及軟體和服務。 2022年，試劑和試劑盒細分市場在亞太體外診斷市場中佔據最大佔有率。

根據技術，亞太體外診斷市場分為免疫分析/免疫化學、臨床化學、分子診斷、微生物學、血糖自我監測、凝血止血、血液學、尿液分析等。 2022 年，免疫分析/免疫化學領域在亞太體外診斷市場中佔據最大佔有率。

根據應用，亞太體外診斷市場分為傳染病、糖尿病、腫瘤學、心臟病學、自體免疫疾病、腎臟病學等。 2022年，傳染病領域在亞太體外診斷市場中佔據最大佔有率。

根據最終用戶，亞太體外診斷市場分為醫院、實驗室、家庭護理等。 2022年，醫院細分市場在亞太體外診斷市場中佔據最大佔有率。

依國家/地區分類，亞太地區體外診斷市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國將主導亞太體外診斷市場。

Abbott Laboratories、Becton Dickinson and Co、bioMerieux SA、Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Qiagen NV、Siemens AG 和 Thermo Fisher Scientific Inc 是亞太地區營運的一些領先公司體外診斷市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區體外診斷市場 - 主要產業動態

  • 主要市場促進因素
    • 慢性病和傳染病的盛行率不斷增加
    • COVID-19 大流行期間床邊檢測的成長和 IVD 需求的激增
  • 市場約束
    • 監理框架和報銷政策不足
  • 市場機會
    • IVD 與數位健康科技的整合
  • 未來的趨勢
    • 對個人化醫療和基因組學的需求不斷成長

第 5 章：亞太體外診斷市場 - 全球市場分析

  • 2022 - 2030 年亞太地區體外診斷市場收入

第 6 章：亞太地區體外診斷市場 - 收入和 2030 年預測 - 按產品和服務

  • 概述
  • 2022 年和 2030 年亞太地區體外診斷市場收入佔有率（按產品和服務分類）（%）
  • 試劑和試劑盒
  • 軟體和服務
  • 儀器

第 7 章：亞太地區體外診斷市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年及 2030 年亞太地區體外診斷市場收入佔有率（按技術分類）（%）
  • 免疫測定/免疫化學
  • 臨床化學
  • 分子診斷
  • 微生物學
  • 血糖自我監測
  • 凝血與止血
  • 血液學
  • 尿液分析
  • 其他

第 8 章：亞太地區體外診斷市場 - 2030 年收入與預測 - 按應用

  • 概述
  • 2022 年及 2030 年亞太地區體外診斷市場收入佔有率，依應用分類 (%)
  • 傳染病
  • 糖尿病
  • 腫瘤學
  • 心臟病學
  • 自體免疫疾病
  • 腎臟病學
  • 其他

第 9 章：亞太地區體外診斷市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年及 2030 年亞太地區體外診斷市場收入佔有率（按最終用戶分類）（%）
  • 醫院
  • 實驗室
  • 居家護理
  • 其他

第 10 章：亞太地區體外診斷市場 - 2030 年收入與預測 - 國家分析

    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 亞太地區其他地區

第 11 章：產業格局

  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：公司簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Thermo Fisher Scientific Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Qiagen NV

第 13 章：附錄

Product Code: TIPRE00022120

The Asia Pacific in-vitro diagnostics market is expected to grow from US$ 19,109.18 million in 2022 to US$ 30,943.27 million by 2030. It is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Integration of IVD Technologies with Digital Health Solutions Fuels Asia Pacific In-Vitro Diagnostics Market

IVD is used in clinical, laboratory, and outpatient settings with the aim specifically to help in the detection of diseases and, consequently, aid in the selection of appropriate treatment protocols. The integration of IVD technologies with digital health solutions is gaining traction globally. Data analytics, artificial Intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. IVD technologies integrated with digital health solutions can be incorporated into clinical decision support systems. As recognized by the WHO, digital health solutions could help detect diseases. Artificial intelligence health bots and similar other emerging solutions may present opportunities for patient care and address challenges such as high cost and time requirements. In diagnostics based on genomic testing, deep learning can identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific sample. Artificial intelligence and machine learning (AI/ML) in in-vitro diagnostics are revolutionizing medical device development. These modern diagnostic systems facilitate diagnosis based on digital image analysis, thereby improving healthcare decision-making. Smart diagnostics are extremely scalable IVD solutions that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, this type of diagnostics can derive emergent features through unique chemical and biological signature detection and analysis. Thus, the integration of IVD with digital health technologies is likely to offer lucrative opportunities to the in-vitro diagnostics market in the coming years.

Asia Pacific In-Vitro Diagnostics Market Overview

The Asia Pacific in-vitro diagnostics market has been segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in China is high attributed to the rising awareness of the disease diagnosis. India holds third largest share in terms of in-vitro diagnostics owing to high prevalence of diseases across the country. The aforementioned factors are responsible for influential growth of in-vitro diagnostics market in the Asia Pacific region. There has been a growth in cancer incidence and mortality rates in China, which has made cancer the primary cause of death in the last decade in the country. The majority of the increasing cases are due to population growth (particularly an upsurge in the elderly population) and socio-demographic changes. Q2 Solutions, a clinical trial laboratory services organization, collaborated with Guangzhou KingMed Diagnostics to develop in-vitro diagnostics products and companion diagnostics (CDx) for the Chinese market. Moreover, several players are investing in the expansion of the cancer biomarkers market. In August 2018, Ipsos' Healthcare Service Line launched the syndicated lab mapping study and oncology molecular diagnostics (MDx) monitor. These two studies will offer comprehensive oncology biomarker testing in China's tier I and tier II cities.

Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific In-Vitro Diagnostics Market Segmentation

The Asia Pacific in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the Asia Pacific in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on technology, the Asia Pacific in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on application, the Asia Pacific in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on end user, the Asia Pacific in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on country, the Asia Pacific in-vitro diagnostics market is segmented int o China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific in-vitro diagnostics market in 2022.

Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific in-vitro diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific In-Vitro Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
  • 4.2 Market Restraint
    • 4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
  • 4.3 Market Opportunities
    • 4.3.1 Integration of IVD with Digital Health Technologies
  • 4.4 Future Trends
    • 4.4.1 Increasing Demand for Personalized Medicine and Genomics

5. Asia Pacific In-Vitro Diagnostics Market - Global Market Analysis

  • 5.1 Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 6.1 Overview
  • 6.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 6.3 Reagents and Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Software and Services
    • 6.4.1 Overview
    • 6.4.2 Software and Services: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Instruments
    • 6.5.1 Overview
    • 6.5.2 Instruments: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Immunoassay/ Immunochemistry
    • 7.3.1 Overview
    • 7.3.2 Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Clinical Chemistry
    • 7.4.1 Overview
    • 7.4.2 Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Molecular Diagnostics
    • 7.5.1 Overview
    • 7.5.2 Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Microbiology
    • 7.6.1 Overview
    • 7.6.2 Microbiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Blood Glucose Self-Monitoring
    • 7.7.1 Overview
    • 7.7.2 Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Coagulation and Hemostasis
    • 7.8.1 Overview
    • 7.8.2 Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Hematology
    • 7.9.1 Overview
    • 7.9.2 Hematology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Urinalysis
    • 7.10.1 Overview
    • 7.10.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.11 Others
    • 7.11.1 Overview
    • 7.11.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Infectious Disease
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diabetes
    • 8.4.1 Overview
    • 8.4.2 Diabetes: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oncology
    • 8.5.1 Overview
    • 8.5.2 Oncology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Autoimmune Diseases
    • 8.7.1 Overview
    • 8.7.2 Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Nephrology
    • 8.8.1 Overview
    • 8.8.2 Nephrology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Laboratories
    • 9.4.1 Overview
    • 9.4.2 Laboratories: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Asia Pacific In-Vitro Diagnostics Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country
      • 10.1.2.1 China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 China: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.1.4 China: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.5 China: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.6 China: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Japan: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Japan: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Japan: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.6 Japan: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 India: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.3.4 India: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.5 India: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.6 India: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.4 Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.3 Australia: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.4.4 Australia: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.4.5 Australia: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.4.6 Australia: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.5 South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.3 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.5.4 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.5.5 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.5.6 South Korea: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.6.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

  • 11.1 Organic Developments
    • 11.1.1 Overview
  • 11.2 Inorganic Developments
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danaher Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Siemens AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Thermo Fisher Scientific Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Becton Dickinson and Co
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 bioMerieux SA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Qiagen NV
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific In-Vitro Diagnostics Market Segmentation
  • Table 2. Death Rate Of Cancer in 2020 Globally
  • Table 3. China Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. India Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. India Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Australia Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Australia Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Australia Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Australia Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. South Korea Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. South Korea Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. South Korea Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. South Korea Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Organic Developments Done by Companies
  • Table 28. Inorganic Developments Done by Companies
  • Table 29. Glossary of Terms, Asia Pacific In-Vitro Diagnostics Market

List Of Figures

  • Figure 1. Asia Pacific In-Vitro Diagnostics Market Segmentation, By Country
  • Figure 2. Asia Pacific In-Vitro Diagnostics Market: Key Industry Dynamics
  • Figure 3. Asia Pacific In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 6. Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Software and Services: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Instruments: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 10. Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microbiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hematology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Urinalysis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 20. Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diabetes: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Oncology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Cardiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Nephrology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Laboratories: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Homecare: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Asia Pacific In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 34. China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)